Indiana University

Todd Parody

Richard Dennis DiMarchi

Yan Zhao

Jonathan Meyers

Zachary Kaur

Yulia Azriel

Jie Han

Pengyun Li

Zach Kaur

Julia Azriel

Richard D Dimarchi

Disclosed herein are insulin agonist peptides conjugated to a glucagon analog wherein the insulin/glucagon conjugate is targeted to liver tissues upon administration to a patient.

Insulin-incretin conjugates

Single chain insulin analogs are provided having high potency and specificity for the insulin receptor. As disclosed herein optimally sized linking moieties can be used to link human insulin A and B chains, or analogs or derivatives thereof, wherein the carboxy terminus of the B25 amino acid of the B chain is linked to the amino terminus of the A1 amino acid of the A chain via the intervening linking moiety. In on embodiment the linking moiety comprises a polyethylene glycol of 6-16 monomer units and in an alternative embodiment the linking moiety comprises a non-native amino acid sequence derived form the IGF-1 C-peptide and comprising at least 8 amino acids and no more than 12 amino acid in length. Also disclosed are prodrug and conjugate derivatives of the single chain insulin analogs.

Single chain insulin agonists exhibiting high activity at the insulin receptor

Single-chain insulin agonists exhibiting high activity at the insulin receptor

Growing community of inventors

Bloomington, IN, United States of America

Todd Parody